Copyright
©The Author(s) 2023.
World J Gastroenterol. Oct 21, 2023; 29(39): 5452-5470
Published online Oct 21, 2023. doi: 10.3748/wjg.v29.i39.5452
Published online Oct 21, 2023. doi: 10.3748/wjg.v29.i39.5452
Figure 4 The protective effect of prostaglandin F2α synthase on DNA damage induced by oxaliplatin in colorectal cancer cells.
A and B: DNA damage marker protein γ-H2A histone family member X (γ-H2AX) was determined using western blot in HCT116 and HCT8 cells and HCT116-OxR and HCT8-OxR cells; C: γ-H2AX fluorescent spots were detected using immunofluorescence staining; D and E: Detection of DNA damage using single-cell gel electrophoresis (comet assay) in parent and drug-resistant cells (scale bar, 50 μm). aP < 0.05, bP < 0.01, cP < 0.001. PGFS: Prostaglandin F2α synthase; Oxa: Oxaliplatin; γ-H2AX: γ-H2A histone family member X.
- Citation: Wang YJ, Xie XL, Liu HQ, Tian H, Jiang XY, Zhang JN, Chen SX, Liu T, Wang SL, Zhou X, Jin XX, Liu SM, Jiang HQ. Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism. World J Gastroenterol 2023; 29(39): 5452-5470
- URL: https://www.wjgnet.com/1007-9327/full/v29/i39/5452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i39.5452